Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Annals of Hematology|April 27, 2011
Elevated frequencies of leukemic myeloid and plasmacytoid dendritic cells in acute myeloid leukemia with the FLT3 internal tandem duplicationMareike Rickmann, Juergen Krauter, Kathrin Stamer, et al.Cancer Genetics and Cytogenetics|August 6, 2005
Cytogenetic characterization of a BCR-ABL transduced mouse cell lineCornelia Rudolph, Ahmed N Hegazy, Nils von Neuhoff, et al.Human Gene Therapy|August 21, 2004
Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitroRichard C Koya, Jeffrey S Weber, Nori Kasahara, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene deliveryRichard C Koya, Nori Kasahara, Patricia M B Favaro, et al.Human Gene Therapy|March 12, 2020
Adult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus InfectionsHenning Olbrich, Sebastian J Theobald, Constanze Slabik, et al.Retrovirology|March 13, 2016
TLR8 regulation of LILRA3 in monocytes is abrogated in human immunodeficiency virus infection and correlates to CD4 counts and virus loadsHui Zhi Low, Gerrit Ahrenstorf, Claudia Pommerenke, et al.Annals of Hematology|April 26, 2013
Monitoring dendritic cell and cytokine biomarkers during remission prior to relapse in patients with FLT3-ITD acute myeloid leukemiaMareike Rickmann, Laura Macke, Bala Sai Sundarasetty, et al.Transfusion|March 29, 2014
Semaphorin 3A alters endothelial cell immunogenicity by regulating Class II transactivator activity circuitsLaura Schlahsa, HaiJiao Zhang, Anja Battermann, et al.Plos One|December 24, 2013
Association of the LILRA3 deletion with B-NHL and functional characterization of the immunostimulatory moleculeHui Zhi Low, Sandra Reuter, Michael Topperwien, et al.Cytotherapy|March 15, 2016
Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cellsMariana Pereira Pinho, Bala Sai Sundarasetty, Patricia Cruz Bergami-Santos, et al.Pageof 6